All Type of News
Government to tackle uninsured medical fees
The government plans to cope with growing public complaints associated with health care not covered by National Health Insurance – elective medical service, uninsurable patient room and high costs of caregivers.
To...
Plural CEO system favored in 21 drug firms
Twenty one of 56 pharmaceutical companies have adopted the system of more than two chief executive officers (CEO) to ensure more efficient company management, according to Yakup.com, a pharmaceutical information websi...
Ahn says will be a mediator to end clash over prescription rights
Former presidential candidate Ahn Cheol-soo returned from the U.S. to prepare for the April 24 by-election said last Friday he will step in to resolve a deepening feud between pharmacists and doctors over drug prescri...
Boryung Pharma wins patent lawsuit
The landscape of the nation’s pharmaceutical market is expected to change as Boryung Pharmaceutical has won a patent suit against Novartis, the world’s biggest player in the sector.
Boryung was successful in its le...
BMS Korea, AstraZeneca Korea expand diabetes alliance
BMS Korea and AstraZeneca Korea received the Korean marketing rights of Byetta (exenatide) injection and Bydureon (exenatide extended-release for injectable suspension) from Lilly Korea as of April 1, following the su...
Leading drug makers’ outpatient sales drop in 2012
Korea's ten leading companies witnessed their outpatient sales tumble last year from a year earlier, data showed Monday.
Outpatient sales by ten companies stood at 2.69 trillion won last year, down 10.8 percent fro...
Kowa Group eyes expansion of OTC business in Korea
Japan’s Kowa Group is looking to expand into the country’s over-the-counter (OTC) markets by establishing its Korea unit “Kowa Korea Company” in December 2011.
“We are planning to penetrate the OTC markets with our...
Will drug makers tackle ongoing tension with doctors?
Eyes are drawn to whether the ongoing tension between pharmaceutical firms and hospitals will affect the former’s revenue that is directly linked with doctors’ prescription.
Drug makers and doctors are still at odd...
Skepticism mounting over new KPA executives
The Korean Pharmaceutical Association (KPA) is expected to negotiate with the National Health Insurance Corporation (NHIC) in May over next year’s pharmacy insurance fee.
However, some KPA critics are skeptical abo...
Drug makers, wholesalers team up for earlier settlement of drug payment
Pharmaceutical companies and wholesalers agreed to launch a task force in a move to shorten the delayed drug payment by hospitals.
The task force launching plan came after Rep. Oh Je-se recently proposed a bill aim...
